Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Knee bursitis, characterized by the irritation of the bursae across the knee joint, is a commonplace condition affecting individuals of all ages, with growing occurrence due to factors consisting of the aging population and sports activities injuries. Technological improvements in diagnostic imaging strategies, including MRI and ultrasound, are useful resources in accurate diagnosis, contributing to market increase via facilitating well-timed remedy initiation. Various treatment options for Knee bursitis, inclusive of relaxation, ice therapy, bodily therapy, nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroid injections, and, in intense cases, surgical intervention, provide a different market panorama catering to the distinctive affected person's desires. Patient choices for minimally invasive treatments, inclusive of corticosteroid injections or bodily therapy over surgical interventions, affect market dynamics, riding demand for less invasive alternatives.
Intense competition among pharmaceutical companies and scientific device manufacturers presenting Knee bursitis remedy options drives innovation and market growth, leading to progressed patient consequences. Continuous advancements in the clinical era, consisting of the development of superior orthopedic gadgets and minimally invasive surgical techniques, beautifying remedy efficacy and affected person satisfaction, using market demand. The growing old population, especially in evolved areas, is using market increase due to the higher incidence of Knee bursitis amongst older adults, necessitating effective remedy alternatives. The increasing participation in sports activities and bodily activities globally contribute to the occurrence of Knee bursitis, developing demand for specialized remedy options catering to athletes and sports activities enthusiasts. The demand for effective ache control answers for Knee bursitis patients, inclusive of both pharmacological and non-pharmacological interventions, influences market dynamics, with a focal point on improving patient consolation and mobility.
Mergers and acquisitions among key market gamers lead to market consolidation, influencing pricing techniques and product availability, thereby shaping market dynamics. The adoption of telemedicine for far-off consultations and follow-up care in Knee bursitis management impacts market dynamics, improving admission to specialized healthcare services and using market growth. Emphasis on affected person-pronounced outcomes and exceptional-of-life measures in clinical trials and treatment opinions impacts remedy possibilities and market dynamics, with a focus on reaching higher long-term consequences for patients. The association of Knee bursitis with other musculoskeletal situations, along with osteoarthritis and rheumatoid arthritis, influences remedy strategies and market dynamics, driving demand for multimodal techniques to control. Economic elements, along with healthcare spending, reimbursement regulations, and disposable profit tiers, affect market dynamics by affecting treatment accessibility and affordability across special regions.
Knee Bursitis Market Highlights:
Knee Bursitis Market Overview
Knee Bursitis Market Size was valued at USD 0.32 Billion in 2023. The Global Knee Bursitis industry is projected to grow from USD 0.73 Billion in 2024 to USD 4.57 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.10% during the forecast period (2024 - 2032).
Knee bursitis is inflammation of a small fluid-filled sac (bursa) situated near the knee joint. Bursae reduce friction and cushion pressure points between bones and the tendons, muscles, and skin near joints. Knee bursitis signs and symptoms vary, depending on which bursa is affected and what's causing the inflammation. Generally, the affected portion of knee might feel warm, tender, and swollen when pressure is applied. But most cases of knee bursitis result from friction and irritation of the bursa that occurs in jobs that require a lot of kneeling on hard surfaces.
Knee bursitis can be caused by frequent and sustained pressure, such as kneeling, especially on hard surfaces, overuse or strenuous activity, a direct blow to the knee, a bacterial infection of the bursa, complications from osteoarthritis, and others. Risk factors for knee bursitis is a common complaint, but the risk of developing this painful disorder can increase from prolonged kneeling. For instance, people who work on their knees for long periods such as carpet layers, plumbers, and gardeners are at increased risk of knee bursitis. Sports that result in direct blows or frequent falls on the knee such as wrestling, football, and volleyball can increase your risk of knee bursitis. Runners can develop pain and inflammation in the pes anserine bursa, situated on the inner side knee below the joint.
The global knee bursitis market is expecting a sound growth in the coming future owing to the increasing prevalence of bone-related diseases and favorable reimbursement policies. Mostly all diabetic patients suffer from some or the other knee bursitis. According to findings from the WHO in 2014, approximately 422 million people reported suffering from diabetes. Due to the increasing diabetic population across the globe, there is a significant increase in the number of people with knee bursitis. Additionally, increasing geriatric population and increasing healthcare expenditure have fuelled the growth of the market. On the other hand, strict regulatory rules and the high cost of the treatment methods may slow the growth of the market during the forecast period.
Figure- Global Knee Bursitis Market, by region 2016(%) 
Knee Bursitis Market Segmentation
The global knee bursitis market has been segmented on the basis of diagnosis, treatment, and end users.
On the basis of the diagnosis, the global knee bursitis market is segmented into imaging tests and others. Imaging tests are further segmented into X-ray, MRI, ultrasound, and others.
Based on the treatment, it is segmented medication, therapy, surgery, and others. Medication is sub-segmented into antibiotic treatment and others. Others segment includes corticosteroid injection and others.
On the basis of the end users, the market is segmented into hospitals & clinics, diagnostic centers, research centers, academic institutes, and others.
Knee Bursitis Market Regional Analysis
The Americas accounted for the major share of the market owing to the presence of a huge population of patients suffering from bone related problems or joint pains, high healthcare expenditure, well-developed technology, and the presence of the leading players. Furthermore, rising government support for the development of the advanced devices and well-developed healthcare sector has boosted the growth of the knee bursitis market in the Americas.
Europe accounted for the second largest market for the knee bursitis, which is followed by Asia Pacific. Increasing prevalence of the knee bursitis, diabetes, and huge healthcare spending are the major driving factors that have boosted the market growth. Additionally, the healthcare expenditure in this region is also rising. People and healthcare organizations in this region are able to afford the high cost of the devices, which is driving the growth of the market. Furthermore, increasing government support and funding for the development and improvement of the treatments have fuelled the growth of the market.
The Asia Pacific is the fastest growing knee bursitis market. Increasing need for better devices, rapidly improving technology, and the presence of huge patient pool is driving the growth of the market in this region.
The Middle East & Africa holds the least share of the market owing to the presence of poor and slow developing countries, especially, in the African region. The major driving factors for the growth of the Middle East & African knee bursitis market are increasing aging population and increasing number of diabetic patients.
Key Players in the Knee Bursitis Market
- Novartis AG
- Pfizer Inc
- Amgen Inc
- AVEO Pharmaceuticals Inc
- Bayer AG
- Bellicum Pharmaceuticals Inc
- MediaPharma srl
- Merck & Co., Inc
- Merrimack Pharmaceuticals Inc
- Oncolys BioPharma Inc
- United Therapeutics Corp
Intended Audience
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
